Multi-Omic Approaches in Cancer-Related Micropeptide Identification DOI Creative Commons
Katarina Vrbnjak, Raj Nayan Sewduth

Proteomes, Год журнала: 2024, Номер 12(3), С. 26 - 26

Опубликована: Сен. 13, 2024

Despite the advances in modern cancer therapy, malignant diseases are still a leading cause of morbidity and mortality worldwide. Conventional treatment methods frequently lead to side effects drug resistance patients, highlighting need for novel therapeutic approaches. Recent findings have identified existence non-canonical micropeptides, an additional layer proteome complexity, also called microproteome. These small peptides promising class agents with potential address limitations current treatments. The microproteome is encoded by regions genome historically annotated as non-coding, its has been revealed thanks recent proteomic bioinformatic technology, which dramatically improved understanding complexity. Micropeptides shown be biologically active several types, indicating their role. Furthermore, they characterized low toxicity high target specificity, demonstrating development better tolerated drugs. In this review, we survey landscape known micropeptides role progression or treatment, discuss anticancer agents, describe methodological challenges facing field research.

Язык: Английский

Peptide-Aware Chemical Language Model Successfully Predicts Membrane Diffusion of Cyclic Peptides DOI
Aaron L. Feller, Claus O. Wilke

Journal of Chemical Information and Modeling, Год журнала: 2025, Номер unknown

Опубликована: Янв. 8, 2025

Language modeling applied to biological data has significantly advanced the prediction of membrane penetration for small-molecule drugs and natural peptides. However, accurately predicting diffusion peptides with pharmacologically relevant modifications remains a substantial challenge. Here, we introduce PeptideCLM, peptide-focused chemical language model capable encoding modifications, unnatural or noncanonical amino acids, cyclizations. We assess this by cyclic peptides, demonstrating greater predictive power than existing models. Our is versatile can be extended beyond predictions other target values. Its advantages include ability macromolecules using string notation, largely unexplored domain, simple, flexible architecture that allows adaptation any peptide macromolecule set.

Язык: Английский

Процитировано

1

Prodrug Approach as a Strategy to Enhance Drug Permeability DOI Creative Commons
Mariana Moraes Dionysio de Souza, Ana Luísa Rodriguez Gini,

Jhonnathan Alves Moura

и другие.

Pharmaceuticals, Год журнала: 2025, Номер 18(3), С. 297 - 297

Опубликована: Фев. 21, 2025

Absorption and permeability are critical physicochemical parameters that must be balanced to achieve optimal drug uptake. These key factors closely linked the maximum absorbable dose required provide appropriate plasma levels of drugs. Among various strategies employed enhance solubility permeability, prodrug design stands out as a highly effective versatile approach for improving properties enabling optimization biopharmaceutical pharmacokinetic while mitigating adverse effects. Prodrugs compounds with reduced or no activity that, through bio-reversible chemical enzymatic processes, release an active parental drug. The application this technology has led significant advancements in during phase, it offers broad potential further development. Notably, approximately 13% drugs approved by U.S. Food Drug Administration (FDA) between 2012 2022 were prodrugs. In review article, we will explore describing examples market We also describe use optimize PROteolysis TArgeting Chimeras (PROTACs) using conjugation technologies. highlight some new technologies prodrugs enrich properties, contributing developing safe

Язык: Английский

Процитировано

0

Cyclic peptide membrane permeability prediction using deep learning model based on molecular attention transformer DOI Creative Commons
Dawei Jiang, Zixi Chen, Hongli Du

и другие.

Frontiers in Bioinformatics, Год журнала: 2025, Номер 5

Опубликована: Март 11, 2025

Membrane permeability is a critical bottleneck in the development of cyclic peptide drugs. Experimental membrane testing costly, and precise silico prediction tools are scarce. In this study, we developed CPMP ( https://github.com/panda1103/CPMP ), model based on Molecular Attention Transformer (MAT) frame. The demonstrated robust predictive performance, achieving determination coefficients R 2 ) 0.67 for PAMPA prediction, values 0.75, 0.62, 0.73 Caco-2, RRCK, MDCK cell predictions, respectively. Its performance outperforms traditional machine learning methods graph-based neural network models. ablation experiments, validated effectiveness each component MAT architecture. Additionally, analyzed impact data pre-training conformation optimization performance.

Язык: Английский

Процитировано

0

Peptide-specific chemical language model successfully predicts membrane diffusion of cyclic peptides DOI Creative Commons
Aaron L. Feller, Claus O. Wilke

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Авг. 9, 2024

Language modeling applied to biological data has significantly advanced the prediction of membrane penetration for small molecule drugs and natural peptides. However, accurately predicting diffusion peptides with pharmacologically relevant modifications remains a substantial challenge. Here, we introduce PeptideCLM, peptide-focused chemical language model capable encoding modifications, unnatural or non-canonical amino acids, cyclizations. We assess this by cyclic peptides, demonstrating greater predictive power than existing models. Our is versatile can be extended beyond predictions other target values. Its advantages include ability macromolecules using string notation, largely unexplored domain, simple, flexible architecture that allows adaptation any peptide macromolecule dataset.

Язык: Английский

Процитировано

0

Multi-Omic Approaches in Cancer-Related Micropeptide Identification DOI Creative Commons
Katarina Vrbnjak, Raj Nayan Sewduth

Proteomes, Год журнала: 2024, Номер 12(3), С. 26 - 26

Опубликована: Сен. 13, 2024

Despite the advances in modern cancer therapy, malignant diseases are still a leading cause of morbidity and mortality worldwide. Conventional treatment methods frequently lead to side effects drug resistance patients, highlighting need for novel therapeutic approaches. Recent findings have identified existence non-canonical micropeptides, an additional layer proteome complexity, also called microproteome. These small peptides promising class agents with potential address limitations current treatments. The microproteome is encoded by regions genome historically annotated as non-coding, its has been revealed thanks recent proteomic bioinformatic technology, which dramatically improved understanding complexity. Micropeptides shown be biologically active several types, indicating their role. Furthermore, they characterized low toxicity high target specificity, demonstrating development better tolerated drugs. In this review, we survey landscape known micropeptides role progression or treatment, discuss anticancer agents, describe methodological challenges facing field research.

Язык: Английский

Процитировано

0